| Literature DB >> 33648633 |
Kathryn Milne1, Alasdair Ivens1,2, Adam J Reid3, J Alexandra Rowe1,2, Philip J Spence1,2, Magda E Lotkowska3, Aine O'Toole2,4, Geetha Sankaranarayanan3, Diana Munoz Sandoval1,5, Wiebke Nahrendorf1, Clement Regnault6,7, Nick J Edwards8, Sarah E Silk8, Ruth O Payne8, Angela M Minassian8, Navin Venkatraman8, Mandy J Sanders3, Adrian Vs Hill8, Michael Barrett6,7, Matthew Berriman3, Simon J Draper8.
Abstract
Falciparum malaria is clinically heterogeneous and the relative contribution of parasite and host in shaping disease severity remains unclear. We explored the interaction between inflammation and parasite variant surface antigen (VSA) expression, asking whether this relationship underpins the variation observed in controlled human malaria infection (CHMI). We uncovered marked heterogeneity in the host response to blood challenge; some volunteers remained quiescent, others triggered interferon-stimulated inflammation and some showed transcriptional evidence of myeloid cell suppression. Significantly, only inflammatory volunteers experienced hallmark symptoms of malaria. When we tracked temporal changes in parasite VSA expression to ask whether variants associated with severe disease rapidly expand in naive hosts, we found no transcriptional evidence to support this hypothesis. These data indicate that parasite variants that dominate severe malaria do not have an intrinsic growth or survival advantage; instead, they presumably rely upon infection-induced changes in their within-host environment for selection.Entities:
Keywords: P. falciparum; falciparum malaria; human; human immune variation; immunology; infectious disease; inflammation; metabolomics; microbiology; systems immunology; var gene switching
Mesh:
Substances:
Year: 2021 PMID: 33648633 PMCID: PMC7924948 DOI: 10.7554/eLife.62800
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140